What have pharmacies paid for Imatinib Mesylate since 2013?
What pharmacies pay, not what you pay. Imatinib Mesylate has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Imatinib Mesylate 400 MG Tab: $182 per unit at the 2016 survey and $2.68 at 2026 (−99%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Imatinib Mesylate2 products in NADAC
2products with a price history
Imatinib Mesylate has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 2 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Imatinib Mesylate 400 MG Tab
Generic
$182 per unit at the 2016 year-end survey (5 NDCs) and $2.68 at the 2026 survey (15 NDCs): −99%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2016 (2016-12-28)
$182
5
2017 (2017-12-27)
$124
8
2018 (2018-12-26)
$20.40
13
2019 (2019-12-25)
$9.33
18
2020 (2020-12-30)
$5.92
18
2021 (2021-12-29)
$3.67
20
2022 (2022-12-28)
$2.46
21
2023 (2023-12-27)
$1.78
19
2024 (2024-12-25)
$2.56
17
2025 (2025-12-31)
$3.09
15
2026 (2026-11-11)
$2.68
15
Imatinib Mesylate 100 MG Tab
Generic
$68.17 per unit at the 2016 year-end survey (5 NDCs) and $0.644 at the 2026 survey (17 NDCs): −99%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2016 (2016-12-28)
$68.17
5
2017 (2017-12-27)
$46.79
8
2018 (2018-12-26)
$6.09
13
2019 (2019-12-25)
$4.95
18
2020 (2020-12-30)
$3.14
18
2022 (2022-12-28)
$0.812
21
2023 (2023-12-27)
$0.609
21
2024 (2024-12-25)
$0.668
17
2025 (2025-12-31)
$0.874
19
2026 (2026-11-11)
$0.644
17
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
How many companies make Imatinib Mesylate?
The FDA Orange Book lists 12 generic makers as marketed in its largest dosage form for Imatinib Mesylate, and the first generic approval is dated 3 December 2015. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.